Haisco Pharmaceutical Group Co., Ltd. (SHE:002653)
China flag China · Delayed Price · Currency is CNY
42.97
-0.95 (-2.16%)
Jun 6, 2025, 2:45 PM CST

Haisco Pharmaceutical Group Company Description

Haisco Pharmaceutical Group Co., Ltd. research, develops, manufactures, and sells pharmaceuticals products in China.

The company offers anesthetic analgesic, neuropsychiatric system, digestive liver disease, and parenteral nutrition medications; drugs for endocrine system and cardiovascular system; oncology-related drugs; andrology drugs; desonide and liprocaine cream; propofol medium/long chain fat emulsion and hydroxyethyl starch sodium chloride injection; sodium fusidicate ointment; lupatadine fumarate tablets; and caspofungin acetate and methylprednisolone sodium succinate for injection.

It also develops Sisuning for sedation and anaesthesia during surgery/procedure for non-endotracheal intubation, general anesthesia induction and maintenance, sedation during mechanical ventilation during intensive care, pediatric indications, and general anesthesia induction; Simenine for diabetic peripheral neuralgia, postherpetic neuralgia, and central nervous system analgesia; Beichangping for type 2 diabetes; Sysojing for postoperative analgesia of abdominal surgery, chronic kidney disease itching, orthopedic analgesia, and postoperative nausea and vomiting; HSK31858 for non-cystic fibrosis bronchiectasis, bronchial asthma, chronic obstructive pulmonary disease, and expectorant; HSK31679 for nonalcoholic steatohepatitis; HSK39297 for PHN of hemolytic disease and primary or secondary glomerular disease; HSK39775 and HSK42360 for advanced solid tumors; HSK39004 and HL231 for chronic obstructive pulmonary disease; HSK44459 for interstitial lung disease; HSK46575 for prostate cancer; and HSK41959 for advanced solid tumors.

It offer its products for anesthesia; analgesia; and chronic metabolic, respiratory, and autoimmune diseases, etc. The company was formerly known as Xizang Haisco Pharmaceutical Group Co., Ltd. and changed its name to Haisco Pharmaceutical Group Co., Ltd. in March 2016.

Haisco Pharmaceutical Group Co., Ltd. was founded in 2005 and is based in Shannan, China.

Haisco Pharmaceutical Group Co., Ltd.
Country China
Founded 2005
Industry Biotechnology
Sector Healthcare
Employees 5,337
CEO Xiu Lian Fan

Contact Details

Address:
No.17, Sanxiang Avenue
Shannan, 856000
China
Phone 86 89 3783 4865
Website haisco.com

Stock Details

Ticker Symbol 002653
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE100001BC7
SIC Code 2834

Key Executives

Name Position
Xiu Lian Fan MD, GM and Director
Peng Duan Chief Financial Officer
Meng Wang Deputy GM and Board Secretary
Han Bing Liu Human Resources Manager